Ackermans & Van Haaren Supports MRM Health's Series B Financing Round Of 55 Million Euros

2025-09-04 01:15:59

(MENAFN- GlobeNewsWire - Nasdaq) Dear shareholder,

Dear Madam, Dear Sir,

Ackermans & van Haaren (AvH) supports the Series B financing round totaling 55 million euros of MRM Health, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology.

For AvH, this series B financing round involves an additional investment of 3 million euros and brings its total investment in MRM Health to 10.8 million euros and its fully diluted participation to 14.1%.

Please find the full press release in annex.

Best regards

Ackermans & van Haaren

Attachment

Ackermans & van Haaren supports MRM Health's Series B financing round (20250904)

MENAFN04092025004107003653ID1110015416

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.